Holen Sie sich die Stockscreener-App
21.79
1.40%
-0.31
Handel nachbörslich:
21.78
-0.010
-0.05%
Finanzdaten der Dianthus Therapeutics Inc-Aktie (DNTH)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-09-30 |
| Periodenlänge | 3 Monate | 3 Monate |
| Revenues |
5.41%
0.874
|
0.924 |
Operating Expenses
|
12.20%
18.72
|
16.68 |
| Benefits Costs and Expenses |
14.62
|
- |
| Costs And Expenses |
12.20%
18.72
|
16.68 |
| Operating Income/Loss |
13.23%
-17.84
|
-15.76 |
| Nonoperating Income/Loss |
311.24%
4.096
|
0.996 |
| Income/Loss From Continuing Operations Before Tax |
1,588%
-13.75
|
0.924 |
| Income/Loss From Continuing Operations After Tax |
6.88%
-13.75
|
-14.76 |
|
Net Income/Loss
|
6.88%
-13.75
|
-14.76 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- |
| Attributable To Noncontrolling Interest |
-
|
- |
| Basic Average Shares |
556.93%
25.67
|
3.9069 |
| Diluted Average Shares |
556.93%
25.67
|
3.9069 |
| Basic Earnings Per Share |
85.71%
-0.54
|
-3.78 |
| Diluted Earnings Per Share |
85.71%
-0.54
|
-3.78 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- |
3.32%
1.57%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):